---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-029848"
form_type: "8-K"
ticker: "CNTN"
cik: "0001861657"
company_name: "Canton Strategic Holdings, Inc."
filed_at: "2022-10-28T23:59:59+00:00"
generated_at: "2026-06-22T22:55:09.984226+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Hillstream BioPharma receives Nasdaq delisting notice for bid price below $1.00

## Summary
- Received Nasdaq notice on Oct 27, 2022 for non-compliance with minimum bid price rule (30 consecutive days below $1.00).
- Has 180 days (until Apr 25, 2023) to regain compliance by closing at $1.00+ for 10 consecutive business days.
- If not compliant by Apr 25, 2023, may qualify for second 180-day period; failure leads to delisting with appeal option.
- Stock continues trading under symbol HILS; company monitoring options to regain compliance.

## SEC filing metadata
- accession: 0001493152-22-029848
- form_type: 8-K
- ticker: CNTN
- cik: 0001861657
- company_name: Canton Strategic Holdings, Inc.
- filed_at: 2022-10-28T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861657/000149315222029848/0001493152-22-029848-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861657/000149315222029848/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-029848
- JSON: https://secwatch.observer/filing/0001493152-22-029848.json
- Plain text: https://secwatch.observer/filing/0001493152-22-029848.txt

## Key facts
- Listing & Compliance Notices
  Canton Strategic Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: October 27, 2022, Hillstream BioPharma, Inc., a Delaware corporation (the “ Company ”), received written notice (the “ Notice ”) from the Nasdaq Stock Market, LLC (“ Nasdaq ”) indicating that the bid price for the Company’s common stock (the “Common Stock”), for the last 30 consecutive business days, had closed below the minimum $1.00 per share and, as a result, the Company is not in compliance with the $1.00 minimum bid price requirement for the continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2). The Notice has no effect at this time of the Common S
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861657/000149315222029848/0001493152-22-029848-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.